237 related articles for article (PubMed ID: 24907275)
1. Mutation of threonine 34 in mouse podoplanin-Fc reduces CLEC-2 binding and toxicity in vivo while retaining antilymphangiogenic activity.
Bianchi R; Fischer E; Yuen D; Ernst E; Ochsenbein AM; Chen L; Otto VI; Detmar M
J Biol Chem; 2014 Jul; 289(30):21016-27. PubMed ID: 24907275
[TBL] [Abstract][Full Text] [Related]
2. The podoplanin-CLEC-2 interaction promotes platelet-mediated melanoma pulmonary metastasis.
Sheng M; Sun R; Fu J; Lu G
BMC Cancer; 2024 Apr; 24(1):399. PubMed ID: 38561690
[TBL] [Abstract][Full Text] [Related]
3. Podoplanin-Fc reduces lymphatic vessel formation in vitro and in vivo and causes disseminated intravascular coagulation when transgenically expressed in the skin.
Cueni LN; Chen L; Zhang H; Marino D; Huggenberger R; Alitalo A; Bianchi R; Detmar M
Blood; 2010 Nov; 116(20):4376-84. PubMed ID: 20716773
[TBL] [Abstract][Full Text] [Related]
4. C-type lectin-like receptor (CLEC)-2, the ligand of podoplanin, induces morphological changes in podocytes.
Tanaka K; Tanaka M; Watanabe N; Ito M; Pastan I; Koizumi M; Matsusaka T
Sci Rep; 2022 Dec; 12(1):22356. PubMed ID: 36572741
[TBL] [Abstract][Full Text] [Related]
5. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling.
Bertozzi CC; Schmaier AA; Mericko P; Hess PR; Zou Z; Chen M; Chen CY; Xu B; Lu MM; Zhou D; Sebzda E; Santore MT; Merianos DJ; Stadtfeld M; Flake AW; Graf T; Skoda R; Maltzman JS; Koretzky GA; Kahn ML
Blood; 2010 Jul; 116(4):661-70. PubMed ID: 20363774
[TBL] [Abstract][Full Text] [Related]
6. Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells.
Osada M; Inoue O; Ding G; Shirai T; Ichise H; Hirayama K; Takano K; Yatomi Y; Hirashima M; Fujii H; Suzuki-Inoue K; Ozaki Y
J Biol Chem; 2012 Jun; 287(26):22241-52. PubMed ID: 22556408
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2.
Kato Y; Kaneko MK; Kunita A; Ito H; Kameyama A; Ogasawara S; Matsuura N; Hasegawa Y; Suzuki-Inoue K; Inoue O; Ozaki Y; Narimatsu H
Cancer Sci; 2008 Jan; 99(1):54-61. PubMed ID: 17944973
[TBL] [Abstract][Full Text] [Related]
8. A role of platelet C-type lectin-like receptor-2 and its ligand podoplanin in vascular biology.
Suzuki-Inoue K; Tsukiji N
Curr Opin Hematol; 2024 May; 31(3):130-139. PubMed ID: 38359177
[TBL] [Abstract][Full Text] [Related]
9. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2.
Herzog BH; Fu J; Wilson SJ; Hess PR; Sen A; McDaniel JM; Pan Y; Sheng M; Yago T; Silasi-Mansat R; McGee S; May F; Nieswandt B; Morris AJ; Lupu F; Coughlin SR; McEver RP; Chen H; Kahn ML; Xia L
Nature; 2013 Oct; 502(7469):105-9. PubMed ID: 23995678
[TBL] [Abstract][Full Text] [Related]
10. [A role of the platelet receptor CLEC-2 in lymphangiogenesis and its clinical application].
Osada M; Suzuki-Inoue K; Inoue O; Ozaki Y
Rinsho Byori; 2013 Apr; 61(4):318-27. PubMed ID: 23855188
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of recombinant snake venom rhodocytin: rhodocytin mutant blocks CLEC-2/podoplanin-dependent platelet aggregation and lung metastasis.
Sasaki T; Shirai T; Tsukiji N; Otake S; Tamura S; Ichikawa J; Osada M; Satoh K; Ozaki Y; Suzuki-Inoue K
J Thromb Haemost; 2018 May; 16(5):960-972. PubMed ID: 29488681
[TBL] [Abstract][Full Text] [Related]
12. Human podoplanin-positive monocytes and platelets enhance lymphangiogenesis through the activation of the podoplanin/CLEC-2 axis.
Hur J; Jang JH; Oh IY; Choi JI; Yun JY; Kim J; Choi YE; Ko SB; Kang JA; Kang J; Lee SE; Lee H; Park YB; Kim HS
Mol Ther; 2014 Aug; 22(8):1518-1529. PubMed ID: 24736277
[TBL] [Abstract][Full Text] [Related]
13. Podoplanin-rich stromal networks induce dendritic cell motility via activation of the C-type lectin receptor CLEC-2.
Acton SE; Astarita JL; Malhotra D; Lukacs-Kornek V; Franz B; Hess PR; Jakus Z; Kuligowski M; Fletcher AL; Elpek KG; Bellemare-Pelletier A; Sceats L; Reynoso ED; Gonzalez SF; Graham DB; Chang J; Peters A; Woodruff M; Kim YA; Swat W; Morita T; Kuchroo V; Carroll MC; Kahn ML; Wucherpfennig KW; Turley SJ
Immunity; 2012 Aug; 37(2):276-89. PubMed ID: 22884313
[TBL] [Abstract][Full Text] [Related]
14. Physiologic and pathophysiologic roles of interaction between C-type lectin-like receptor 2 and podoplanin: partners from in utero to adulthood.
Suzuki-Inoue K; Osada M; Ozaki Y
J Thromb Haemost; 2017 Feb; 15(2):219-229. PubMed ID: 27960039
[TBL] [Abstract][Full Text] [Related]
15. Essential in vivo roles of the platelet activation receptor CLEC-2 in tumour metastasis, lymphangiogenesis and thrombus formation.
Suzuki-Inoue K
J Biochem; 2011 Aug; 150(2):127-32. PubMed ID: 21693546
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis.
Chang YW; Hsieh PW; Chang YT; Lu MH; Huang TF; Chong KY; Liao HR; Cheng JC; Tseng CP
Oncotarget; 2015 Dec; 6(40):42733-48. PubMed ID: 26528756
[TBL] [Abstract][Full Text] [Related]
17. Platelet adhesion to podoplanin under flow is mediated by the receptor CLEC-2 and stabilised by Src/Syk-dependent platelet signalling.
Navarro-Núñez L; Pollitt AY; Lowe K; Latif A; Nash GB; Watson SP
Thromb Haemost; 2015 May; 113(5):1109-20. PubMed ID: 25694214
[TBL] [Abstract][Full Text] [Related]
18. Development of Core-Fucose-Deficient Humanized and Chimeric Anti-Human Podoplanin Antibodies.
Kaneko MK; Ohishi T; Nakamura T; Inoue H; Takei J; Sano M; Asano T; Sayama Y; Hosono H; Suzuki H; Kawada M; Kato Y
Monoclon Antib Immunodiagn Immunother; 2020 Oct; 39(5):167-174. PubMed ID: 33085938
[TBL] [Abstract][Full Text] [Related]
19. Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets.
Suzuki-Inoue K; Inoue O; Ding G; Nishimura S; Hokamura K; Eto K; Kashiwagi H; Tomiyama Y; Yatomi Y; Umemura K; Shin Y; Hirashima M; Ozaki Y
J Biol Chem; 2010 Aug; 285(32):24494-507. PubMed ID: 20525685
[TBL] [Abstract][Full Text] [Related]
20. Emerging roles of podoplanin in vascular development and homeostasis.
Pan Y; Xia L
Front Med; 2015 Dec; 9(4):421-30. PubMed ID: 26498027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
